Conference report - II. Investigating new vaccines: SARS. Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.
Armandola
Elena
E
European Patent Office, Munich, Germany.
D000818:Animals; D006801:Humans; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology* / Q000302:isolation & purification; D045169:Severe Acute Respiratory Syndrome / Q000517:prevention & control* / Q000635:transmission; D014613:Vaccines, Attenuated / Q000627:therapeutic use; D022223:Vaccines, Subunit / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use*
D014613:Vaccines, Attenuated; D022223:Vaccines, Subunit; D014765:Viral Vaccines